SCHEMBL31723154

SCHEMBL31723154

Cc1ccc2c(=O)c(C(=O)O)c(-c3cc(F)cc(F)c3)oc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.60
ALDH1A1 P00352 4/20 0.60
KDM4E B2RXH2 4/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
HPGD P15428 2/20 0.60
HTT P42858 2/20 0.60
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
ANO1 Q5XXA6 4/20 0.43
CYP3A4 P08684 2/20 0.40
TSHR P16473 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 1/20 0.39
MAOB P27338 1/20 0.39
PTPRC P08575 1/20 0.38
PTPN2 P17706 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20919240 1.00 MAPT (0.60) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL20918210 0.90 MAPT (0.74) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL31723169 0.90 MAPT (0.74) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL31723167 0.89 MAPT (0.62) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL28427603 0.89 MAPT (0.62) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL20918269 0.85 ALDH1A1 (0.57) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL31723177 0.85 ALDH1A1 (0.57) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL28431175 0.83 MAPT (0.68) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL31723158 0.83 MAPT (0.68) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL20919116 0.83 KMT2A (0.56) MAPTALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699174-B1 COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME ILAB (KR) 2025-11-12 EP claimed